ArticleBMC cancer2018

Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1.

Yang Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.